Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Universidad Espíritu Santo Inicio
Español
English
Inicio
Perfiles
Unidades de investigación
Proyectos
Producción científica
Premios
Actividades
Prensa/Medios de comunicación
Buscar por experiencia, nombre o afiliación
The metabolic syndrome among postmenopausal women in Ecuador
Luis A. Hidalgo
,
Peter A. Chedraui
, Nancy Morocho
, Mariela Alvarado
, Diana Chavez
, Angelica Huc
Universidad Católica de Santiago de Guayaquil
Foundation for Health and Well Being in the Climacteric 'FUCLIM'
Producción científica
:
Contribución a una revista
›
Artículo
›
revisión exhaustiva
68
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'The metabolic syndrome among postmenopausal women in Ecuador'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Medicine and Dentistry
Postmenopause
100%
Metabolic Syndrome
100%
Diabetes
57%
Prevalence
57%
Abdominal Obesity
28%
Adenosine Triphosphate
28%
Hormone Therapy
14%
Cardiovascular Disease
14%
Triacylglycerol
14%
Logistic Regression Analysis
14%
Cardiovascular Risk
14%
Odds Ratio
14%
High Risk Population
14%
Hypertriglyceridemia
14%
Blood Pressure Measurement
14%
Nursing and Health Professions
Metabolic Syndrome X
100%
Prevalence
57%
Abdominal Obesity
28%
Adenosine Triphosphate
28%
Hormonal Therapy
14%
Cardiovascular Risk
14%
Odds Ratio
14%
Cardiovascular Disease
14%
Logistic Regression Analysis
14%
Waist Circumference
14%
Confidence Interval
14%
High Risk Population
14%
Glucose Blood Level
14%
Triacylglycerol Level
14%
Hypertriglyceridemia
14%
Blood Pressure Measurement
14%
Lipid Blood Level
14%
Biochemistry, Genetics and Molecular Biology
Postmenopause
100%
Prevalence
80%
Adenosine Triphosphate
40%
Blood Pressure
20%
Lipid Profile
20%
Triacylglycerol Level
20%
High Risk Population
20%
Glucose Blood Level
20%
Medical Biology
20%
Waist Circumference
20%
Hypertriglyceridemia
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metabolic Syndrome X
100%
Prevalence
57%
Abdominal Obesity
28%
Adenosine Triphosphate
28%
Endocrine Therapy
14%
Cardiovascular Disease
14%
Triacylglycerol
14%
Cardiovascular Risk
14%
Hypertriglyceridemia
14%